SCHEMBL23854032

SCHEMBL23854032

CS(=O)(=O)OC[C@H]1CC[C@@H](COCC(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 20/20 0.44
PTGDR Q13258 6/20 0.44
PTGER1 P34995 1/20 0.39
PTGER4 P35408 1/20 0.39
PTGER3 P43115 1/20 0.39
PTGER2 P43116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517491 1.00 PTGIR (0.44) PTGIRPTGDRPTGER1PTGER4PTGER3
SCHEMBL6517494 1.00 PTGIR (0.44) PTGIRPTGDRPTGER1PTGER4PTGER3
Acetic Acid SCHEMBL2479619 0.83 SLC1A3 (0.35)
SCHEMBL937100 0.83
SCHEMBL7705221 0.81 USP2 (0.42)
SCHEMBL14414058 0.81 USP2 (0.42)
SCHEMBL1062380 0.81
SCHEMBL2376563 0.80 GPR119 (0.32)
SCHEMBL2376559 0.80 GPR119 (0.32)
SCHEMBL25217734 0.79 PLG (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3884934-A1 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2021-09-29 EP disclosed